YSIOS CAPITAL
Ysios Capital is a leading Spanish independent venture capital firm that provides private equity financing to early and mid-stage life science companies that develop disruptive therapeutic products and platform technologies. Founded in 2008, Ysios Capital manages c.a. €350 M through three dedicated funds in life sciences and is led by a team of professionals experienced in building biotech companies.
YSIOS CAPITAL
Industry:
Asset Management Finance Financial Services
Founded:
2008-01-01
Status:
Active
Contact:
+34 94 310 82 19
Technology used in webpage:
CDMon Hosting
Similar Organizations
Cormorant Asset Management
Cormorant Asset Management is an employee-owned hedge fund sponsor that provides its services to pooled investment vehicles.
Janus Henderson Investors
Janus Henderson Investors is an asset manager that helps their clients achieve their financial goals.
Current Advisors List
Board_member
2012-01-01
Current Employees Featured
Joel Jean Mairet Managing Partner and Co - Founder @ Ysios Capital
Managing Partner and Co - Founder
2007-01-01
Paula Olazábal Partner @ Ysios Capital
Partner
2019-04-01
Guillem Laporta Partner @ Ysios Capital
Partner
2018-09-01
Lance Berman Venture Partner @ Ysios Capital
Venture Partner
2018-05-01
Raul Martin Partner @ Ysios Capital
Partner
2019-04-01
Miriam Cortés Executive Assistant & Corporate Communications, Office manager @ Ysios Capital
Executive Assistant & Corporate Communications, Office manager
2008-09-01
Claudia D’Augusta Venture Partner @ Ysios Capital
Venture Partner
2018-09-01
Karen Wagner General Partner @ Ysios Capital
General Partner
2007-08-01
Julia Salaverria Managing Partner @ Ysios Capital
Managing Partner
2007-07-01
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2024-05-29 | ADCendo | Ysios Capital investment in Series A - ADCendo | 16 M EUR |
| 2024-05-07 | Memo Therapeutics | Ysios Capital investment in Series C - Memo Therapeutics | 20 M CHF |
| 2024-03-19 | Engrail Therapeutics | Ysios Capital investment in Series B - Engrail Therapeutics | 157 M USD |
| 2024-02-08 | Neurona Therapeutics | Ysios Capital investment in Series E - Neurona Therapeutics | 120 M USD |
| 2023-11-07 | Kynexis | Ysios Capital investment in Series A - Kynexis | 57 M EUR |
| 2023-08-14 | Xeltis | Ysios Capital investment in Series D - Xeltis | 12.5 M EUR |
| 2023-06-22 | Tagworks Pharmaceuticals | Ysios Capital investment in Series A - Tagworks Pharmaceuticals | 65 M USD |
| 2023-05-25 | VarmX | Ysios Capital investment in Series B - VarmX | 30 M GBP |
| 2023-04-04 | ADCendo | Ysios Capital investment in Series A - ADCendo | 31 M EUR |
| 2022-09-14 | SparingVision | Ysios Capital investment in Series B - SparingVision | 75 M EUR |
More informations about "Ysios Capital"
About us – Ysios Capital
Ysios Capital was founded in 2008 and has offices in San Sebastian and Barcelona. With more than €400M AUM, we are the largest life sciences venture capital firm in Spain, with our investment successes providing a significant …See details»
The Team – Ysios Capital
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a …See details»
Ysios Capital - Crunchbase Investor Profile & Investments
Ysios Capital is a leading Spanish independent venture capital firm that provides private equity financing to early and mid-stage life science companies that develop disruptive therapeutic products and platform technologies. Founded in …See details»
Ysios Capital - Investments, Portfolio & Company Exits - Crunchbase
Ysios Capital 's most notable exits include Mineralys Therapeutics, ... Which industries has this organization had the most exits in? Show . Mineralys Therapeutics Mineralys Therapeutics is a …See details»
Ysios Capital | LinkedIn
Ysios Capital | 6,490 followers on LinkedIn. Backing the breakthroughs of tomorrow | Ysios Capital, a leading Spanish venture capital firm, provides private equity financing to early and …See details»
Ysios Capital - Org Chart, Teams, Culture & Jobs | The Org
Ysios Capital is a leading Spanish independent venture capital firm that provides private equity financing to early and mid-stage life science companies that develop disruptive therapeutic …See details»
Ysios Capital - Funding, Financials, Valuation & Investors
Ysios Capital has raised 3 funds, their latest being Ysios BioFund III. This fund was announced on Jun 10, 2020 and raised a total of . obfuscated. obfuscated. Announced Date . Fund Name . …See details»
Ysios Capital investment portfolio - PitchBook
Ysios Capital General Information Company Description. Founded in 2008, Ysios Capital is a venture capital firm based in San Sebastián, Spain. The firm seeks to invest in biotech ventures developing novel drugs, across a diversity of …See details»
Ysios Capital - Golden
Ysios Capital. Ysios Capital invests in companies in the biotechnology industry focused on therapeutics, human healthcare, and life science companies. Overview Structured Data Issues …See details»
Join Us - Ysios Capital
If you have a PhD in life sciences and are passionate about drug development, the Ysios Capital fellowship programme is a great opportunity to get involved. We seek individuals with a strong scientific background who are eager to step out …See details»
Ysios Capital - EU-Startups
Ysios Capital, a leading Spanish venture capital firm, provides private equity financing to early and mid-stage life science companies that develop disruptive therapeutic products and platform …See details»
Ysios Capital - Recent News & Activity - Crunchbase
Nov 25, 2024 Life-Sciences-Europe — Adcendo–Ysios Capital: investment, 202304 financing round Series A extension totalling €31m incl existing + co-lead investor Ysios Capital News • …See details»
Ysios Capital Investor Information - Funding, Portfolio Companies, …
Ysios Capital is a venture capital fund investing in early to later-stage companies globally. Focused on biotech, pharma, and advanced technological sectors, they provide significant …See details»
Investment Strategy – Ysios Capital
We invest in both asset-centric companies and product-enabling platform technologies with a proprietary pipeline. We are agnostic to the therapeutic modality and our investments feature …See details»
Ysios Capital | Institution Profile - Private Equity International
Ysios Capital. News, insights, analysis and data. Ysios Capital overview. Founded in 2008, Ysios Capital is a Spainish investment firm that targets early-stage investment in life science, …See details»
Ysios Capital - Contacts, Employees, Board Members ... - Crunchbase
Ysios Capital has 9 current employee profiles, including Managing Partner and Co - Founder Joel Jean Mairet. Ysios Capital has 1 board member or advisor, Cristina Garmendia. Contacts. Edit …See details»
Trump Organization Sues Capital One for Closing Its Accounts
Mar 7, 2025 President Trump’s family business sued Capital One on Friday for “unjustifiably terminating” more than 300 of its bank accounts after the Jan. 6, 2021, attack on the Capitol, …See details»
Team – Ysios Capital
Dec 28, 2020 The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the …See details»
Aura Biosciences Reports Q4 and Full Year 2024 Financial Results …
1 day ago Research and development expenses increased to $22.3 million and $73.3 million for the three months and full year ended December 31, 2024, respectively, from $20.3 million and …See details»
TiGenix Business and Financial Update for the First Half 2016
Sep 20, 2016 Leuven (BELGIUM) – September 20, 2016, 07:00h CET – TiGenix NV (Euronext Brussels: TIG), an advanced biopharmaceutical company focused on developing and …See details»